At a glance
ClinicalIndex Comparison RecordN/ACompleted· 72 enrolled
Drug / intervention
Beijing Pins Medical Co., Ltd. Deep Brain Stimulatordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi) Deep Brain Stimulation (DBS) in Patients With Primary Dystonia（RELAX Study）
In Brief
A clinical study evaluating Beijing Pins Medical Co., Ltd. Deep Brain Stimulator for Dystonia. Completed, enrolled 72 participants across 7 sites.
Detailed Summary
The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation (DBS) of the subthalamic nucleus (STN) and globus pallidus internus (GPi) for primary dystonia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDystonia
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 2017
Enrollment StartDec 2017
Primary CompletionSep 2020
Study CompletionDec 2021
TodayJul 2026
First PostedJan 11, 2017
Enrollment StartDec 27, 2017
Primary CompletionSep 13, 2020
Study CompletionDec 17, 2021
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 9.5 years ago
Interventions
Beijing Pins Medical Co., Ltd. Deep Brain Stimulatordevice
Deep Brain Stimulation for primary dystonia subjects